NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases.  They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.

Biotechnology

NeuExcell Therapeutics

NeuExcell Therapeutics' headquarters in State College, PA, United States

CEOs

Jian Sheng

Xi Qin

Egor Zhelezniak

Kun (Quinn) Yao

Tsang-Chih Kuo

Josephine Yang

Yuchen Chen

Jie Xu

J. David Jacobs

Xudong Yin

Peter Tombros

Jonathan Sun

Xin Huang

Gong Chen

NeuExcell Therapeutics' Leadership Team includes Jie Xu and 4 others.

Leadership Team

About

People (3)

Gong Chen

Jie Xu

Xi Qin

Jobs